• GIRENTUXIMAB CHEMBL1743027 Antineoplastic

    Alternate Names:

    Girentuximab
    CA9-SCAN CG250
    WX-G250
    CG-250
    Rencarex
    DB05304

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antineoplastic agent
    Drug Categories N/A
    Drug Groups investigational
    Drug Type small molecule
    (0 More Sources)

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Mechanism of Interaction Carbonic anhydrase IX other
    Direct Interaction yes

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name WX-G250,Rencarex
    Novel drug target Novel Target

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:

    Publications:

    • Version: 5.0.8

    Alternate Names:
    WX-G250 DrugBank Drug Name
    Rencarex Drug Brand

    Drug Info:
    Drug Type small molecule
    Drug Groups investigational

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class monoclonal antibody
    FDA Approval not approved

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: